Compare Li Auto Inc (LI) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Li Auto Inc vs Oscar Health Inc — how do they compare? Li Auto Inc trades at $12.68 (market cap $12.28B), while Oscar Health Inc trades at $29.57 (market cap $8.63B). The key difference: Li Auto Inc is the larger of the two by market cap, and Oscar Health Inc is trading nearer its 52-week high, Li Auto Inc nearer its low. Which is the better fit depends on your goals.
| LI | OSCR | |
|---|---|---|
Market Cap | $12.28B | $8.63B |
Sector | Consumer Cyclical | Health |
52-Week High | $26.69 | $32.18 |
52-Week Low | $11.74 | $10.85 |
Enterprise Value | $1.11B | $4.99B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Li Auto (LI) trades at $12.49, down 2.73% on the day, amid a bearish technical signal and mixed earnings performance. The company reported a net income margin of -1.66% for 2025, with revenue declining to $112.31 billion from $144.5 billion in 2024, while launching new SUV models like the Li L6 in July 2026 to boost deliveries. Analyst consensus is a 'Buy' with a $14.80 price target, but negative cash flow and competitive pressures in China's EV market pose challenges.
Outlook remains cautious due to profitability concerns and volatile cash flows, with near-term risks from domestic competition and global expansion hurdles. The stock offers potential upside if execution improves, but investors should monitor delivery trends and margin recovery amid industry headwinds.
Oscar Health (OSCR) trades at $29.11, up 5.2% with strong recent earnings momentum, beating estimates in Q1 and Q2 2026. The stock shows bearish technical signals but benefits from record profitability and raised 2026 guidance. Revenue surged 70% to $4.9 billion in H1 2026, with net income turning positive at $551 million versus a 2025 loss. Valuation remains attractive with P/S of 0.53, suggesting potential undervaluation versus sector peers.
Outlook is positive given membership growth and cost discipline, but risks include medical cost volatility and competitive pressures. Analyst consensus price target of $32.50 implies 12% upside, though technical resistance near $30 may limit near-term gains. Execution on guidance and sustained margin expansion are key catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Li Auto Inc
Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 90,000 EVs in 2021, accounting for about 2.7% of China's passenger new energy vehicle market. Beyond Li One, the company will expand its product line, including both BEVs and PHEVs, to target a broader consumer base.
Read more on LI →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
